Neoclarityn

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

52 API Suppliers, 13 USDMF, 13 CEP/COS, 4 JDMF, 20 EU WC, 3 KDMF, 7 NDC API, 32 Listed Suppliers

DEVELOPMENTS

22 Drugs in Development

22 Drugs in Development

INTERMEDIATES

13 Intermediate Suppliers

13 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

392 FDF Dossiers, 24 FDA Orange Book, 247 Europe, 6 Canada, 56 South Africa, 59 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 5MG, SOLUTION;ORAL - 0.5MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 2.5MG;120MG

RELATED EXCIPIENT COMPANIES

1 Minakem, 5 Evonik, 3 Rochem International Inc, 23 SPI Pharma, 1 Boai NKY Pharmaceuticals Ltd, 7 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 2 Pfanstiehl, 6 Kirsch Pharma, 1 Panvo Organics, 7 Dr. Paul Lohmann GmbH & Co. KGaA, 1 ACG Worldwide, 9 Actylis, 1 Aeon Procare, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 28 BASF, 1 CD Formulation, 12 Corel Pharma Chem, 7 DFE Pharma, 1 Doshion Polyscience, 1 Esteem Industries, 2 Finar, 11 Gangwal Chemicals, 2 Gloria Interchem, 5 Ideal Cures, 5 Ingredion Pharma Solutions, 26 Kerry, 3 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 16 Microlex e.U, 1 Nanjing Bold Chemical, 2 Neelkanth MineChem, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 3 Novo Excipients, 4 Pharmatrans-Sanaq, 7 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 29 Roquette, 13 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 Silverline Chemicals, 2 The Dow Chemical Company, 2 Valens Pharmachem, 4 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

70 Fillers, Diluents & Binders, 52 Coating Systems & Additives, 39 Direct Compression, 35 Granulation, 32 Disintegrants & Superdisintegrants, 32 Taste Masking, 30 Thickeners and Stabilizers, 29 Controlled & Modified Release, 27 Lubricants & Glidants, 24 Solubilizers, 23 Film Formers & Plasticizers, 22 Chewable & Orodispersible Aids, 21 Parenteral, 18 Topical, 14 Co-Processed Excipients, 12 API Stability Enhancers, 9 Emulsifying Agents, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 4 Rheology Modifiers, 2 Coloring Agents, 1 Soft Gelatin

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 8 News #PharmaBuzz

GLOBAL SALES INFORMATION

7 US Medicaid Prescriptions, 38 Regulatory FDF Prices, 7 Annual Reports

MARKET PLACE

28 APIs, 10 FDF Dossiers, 1 EXCIPIENTS

PATENTS & EXCLUSIVITIES

7 Health Canada Patents

7 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 5 USP, 24 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

Xls

Filters

FILTER :

filter Order Code Reset all filters

2 All

01 1Y0001582

02 1Y0001584

filter CAS Number Reset all filters

filter Reference Standard Reset all filters

Reset Filter

Price Info

Product Main Page

01

EDQM, Council of Europe

Desloratadine for system suitability

Pharma

Not Confirmed

02

EDQM, Council of Europe

Desloratadine

Pharma

Not Confirmed

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Neoclarityn

Neoclarityn

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

52 API Suppliers

13 USDMF

13 CEP/COS

4 JDMF

20 EU WC

3 KDMF

7 NDC API

32 Listed Suppliers

DEVELOPMENTS

22 Drugs in Development

INTERMEDIATES

13 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

392 FDF Dossiers

24 FDA Orange Book

247 Europe

6 Canada

56 South Africa

59 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 5MG

SOLUTION;ORAL - 0.5MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 2.5MG;120MG

RELATED EXCIPIENT COMPANIES

1 Minakem

5 Evonik

3 Rochem International Inc

23 SPI Pharma

1 Boai NKY Pharmaceuticals Ltd

7 Gangwal Healthcare

4 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

2 Pfanstiehl

6 Kirsch Pharma

1 Panvo Organics

7 Dr. Paul Lohmann GmbH & Co. KGaA

1 ACG Worldwide

9 Actylis

1 Aeon Procare

8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

28 BASF

1 CD Formulation

12 Corel Pharma Chem

7 DFE Pharma

1 Doshion Polyscience

1 Esteem Industries

2 Finar

11 Gangwal Chemicals

2 Gloria Interchem

5 Ideal Cures

5 Ingredion Pharma Solutions

26 Kerry

3 Keval Exports

3 Kima Chemical

6 Lonza Capsugel

16 Microlex e.U

1 Nanjing Bold Chemical

2 Neelkanth MineChem

3 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

3 Novo Excipients

4 Pharmatrans-Sanaq

7 Pluviaendo

4 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

29 Roquette

13 Seppic

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

2 Shijiazhuang Huaxu Pharmaceutical

11 Sigachi Industries

4 Silverline Chemicals

2 The Dow Chemical Company

SOLUTION;ORAL - 0.5MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons